PAR 1.67% 30.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-262

  1. 317 Posts.
    lightbulb Created with Sketch. 37
    Good for you. I am not against PR as an individual but certainly as a CEO and Chair he leaves a lot to be desired. I cringe when I watch the presentations. He has improved but is still nowhere near the level that I believe will take this company forward
    I understand the shorters and the SP manipulation and I don't blame PR for that.
    He is probably a great person and we can't doubt his passion and knowledge
    There are no controls in place and he reports to himself
    There was talk of a new CEO search, what happened?
    Let PR be the Chair as he deserves to be involved but bring on a gun marketing/sales guru with knowledge and the right contacts
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.005(1.67%)
Mkt cap ! $106.6M
Open High Low Value Volume
30.5¢ 31.5¢ 29.5¢ $152.7K 501.9K

Buyers (Bids)

No. Vol. Price($)
2 16864 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.5¢ 20426 2
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.